Table 1 Baseline characteristics
From: Role of intraoperative feeding jejunostomy in esophageal cancer surgery
Intraoperative jejunostomy (n = 61) | No intraoperative jejunostomy (n = 353) | p-value | |
|---|---|---|---|
Gender, n (%) | 0.566 | ||
Female | 5 (8) | 22 (6) | – |
Male | 56 (92) | 331 (94) | – |
Age (years old), mean ± SD | 67.0 ± 9.3 | 65.0 ± 8.8 | 0.110 |
Body mass index (kg/m2), mean ± SD | 21.7 ± 3.3 | 23.2 ± 3.3 | 0.001 |
Tumor histology, n (%) | 0.767 | ||
Adenocarcinoma | 3 (5) | 17 (5) | – |
Squamous cell carcinoma | 57 (93) | 324 (92) | – |
Other | 1 (2) | 12 (3) | – |
Hypertension, n (%) | 28 (46) | 153 (43) | 0.710 |
Coronary artery diseases, n (%) | |||
Myocardial infarction | 2 (3) | 8 (2) | 0.634 |
Angina pectoralis | 3 (5) | 23 (6) | 0.814 |
Diabetes, n (%) | 11 (18) | 62 (18) | 0.929 |
Number of pack-years (first–third quartile), median | 29.7 (12–40) | 27.2 (10–40) | 0.446 |
Pathological tumor stagea, n (%) | 0.012 | ||
T0 | 12 (20) | 59 (17) | – |
Tis | 1 (2) | 1 (0) | – |
T1 | 11 (18) | 153 (43) | – |
T2 | 11 (18) | 55 (16) | – |
T3 | 24 (39) | 81 (23) | – |
T4 | 2 (3) | 4 (1) | – |
Pathological nodal stagea, n (%) | 0.177 | ||
N0 | 25 (41) | 191 (54) | – |
N1 | 19 (31) | 101 (29) | – |
N2 | 12 (20) | 43 (12) | – |
N3 | 5 (8) | 18 (5) | – |